alexa Aaron McMurtray | OMICS International
ISSN: 2165-7904

Journal of Obesity & Weight Loss Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Aaron McMurtray

 Dr. Aaron McMurtray
M.D., Ph.D., Director, Brain Injury Program
Neuroscience Center of Ventura County
Ventura County Medical Center
3170 Loma Vista Road, Ventura, CA 93003, USA

Biography

Dr. Aaron McMurtray As an academic neurologist, I currently provide care for indigent HIV-1 seropositive individuals at a university affiliated community hospital. This experience gives me first-hand knowledge of the neurologic complications of this disorder as well as the aspects of care that are currently challenging and need improvement. I have also completed a fellowship in Behavioral Neurology and Neuropsychiatry giving me additional insight into the diagnosis and management of the often complex cognitive and behavioral problems evident in this population. Additionally, by completing a Ph.D. degree in Biomedical Sciences and through my prior work as a faculty member at the University of Hawaii medical school, I have demonstrated the ability to independently design, conduct and publish the results of scientific studies focusing on central and peripheral nervous system complications of HIV-1 infection. In 2008 I received an AAN Clinical Research Training Fellowship Award as well as a grant from the University of Hawaii CRC allowing me to complete an independent research project studying changes in brain structure and function due to HIV-1 infection. Later in 2008 I had the opportunity to benefit from additional training in clinical trials methods by attending the NINDS/NIH Clinical Trials Methods Course in Neurology. Subsequently I have participated in a variety of industry sponsored clinical trials and currently am serving on the leadership team developing ACTG clinical trial number A5324 “Raltegravir Maraviroc Intensification in Neurologic Disease (ReMIND)”.
 

Research Interest

Neurology, HIV, Obesity 

Publications

Global Speakers in the subject

Global Experts in the subject

Top